CytomX Therapeutics, Inc. (CTMX)
Current price: $3.10
These defaults work well for most companies. Only adjust them if you have a specific view on this business's risk profile or long-term growth prospects.
Graham Number
√(22.5 × EPS × Book Value per Share)
Not applicable
Insufficient data: requires EPS, total stockholder equity, and share count.
Earnings Power Value
Normalized after-tax earnings ÷ required return (zero-growth)
Not applicable
Median operating income over the available period is negative — not generating operating earnings on a normalized basis.
DCF Fair Value
Projected free cash flow discounted to present value + terminal value
Not applicable
Company has generated positive free cash flow in fewer than 2 of the last several years. DCF is not reliable for businesses with persistently negative FCF.
P/E Fair Value
Earnings per share × target P/E multiple
Not applicable
EPS data unavailable.
Valuation estimates are models, not investment advice. They are highly sensitive to the assumptions chosen and carry significant uncertainty. Past fundamentals do not guarantee future performance.